Since PI3K/Akt/mTOR signaling is hyperactivated in renal cell carcinoma (RCC), inhibition of PI3K/Akt/mTOR pathway is one of target for cancer treatment [19]–[21]. The gene discussed is MTOR; the disease is renal cell carcinoma.